Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $417.3 million versus the consensus estimate of $426.55 million.

GUIDANCE:

Nu Skin Enterprises sees Q2 2024 EPS of $0.10-$0.20, versus the consensus of $0.34. Nu Skin Enterprises sees Q2 2024 revenue of $420-455 million, versus the consensus of $454.4 million.

Nu Skin Enterprises sees FY2024 EPS of $0.95-$1.35, versus the consensus of $1.14. Nu Skin Enterprises sees FY2024 revenue of $1.73-1.87 billion, versus the consensus of $1.813 billion.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.